NCT01732042

Brief Summary

Determinate the standard values of the retinal venous pressure in a cohort of healthy subjects.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2011

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2011

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

October 24, 2012

Completed
29 days until next milestone

First Posted

Study publicly available on registry

November 22, 2012

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2013

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2013

Completed
Last Updated

December 11, 2013

Status Verified

December 1, 2013

Enrollment Period

1.6 years

First QC Date

October 24, 2012

Last Update Submit

December 10, 2013

Conditions

Healthy

Keywords

retinal venous pressure

Outcome Measures

Primary Outcomes (1)

  • Retinal venous pressure

    Quantification of the retinal venous pressure as a standard value in a cohort of healthy volunteers

    1 hour

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

healthy volunteers

You may qualify if:

  • healthy

You may not qualify if:

  • eye diseases
  • systemic diseases
  • term medication (except contraceptives)
  • pregnancy
  • allergies to the ingredients Alcaine, Tropicamide and Phenylephrine

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Basel, Dept. of Ophthalmology

Basel, 4031, Switzerland

Location

Study Officials

  • Josef Flammer, MD

    University of Basel, Dept. of Ophthalmology

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 24, 2012

First Posted

November 22, 2012

Study Start

November 1, 2011

Primary Completion

June 1, 2013

Study Completion

December 1, 2013

Last Updated

December 11, 2013

Record last verified: 2013-12

Locations

CH(1)